Skip to main content

Table 2 Endoscopic data

From: The role of endoscopy and findings in COVID-19 patients, an early North American Cohort

Procedure  
Endoscopy, n (%) 18 (75)
Colonoscopy, n (%) 7 (29.2)
ERCP, n (%) 2 (8.3)
Type of sedation, n (%) Conscious 6 (25)
MAC 8 (33.3)
General 10 (41.7)
Reason for endoscopy  
 Need for enteral access, n (%) 6 (25)
 Overt Bleeding, n (%) 13 (54.2)
 Anemia without overt bleeding, n (%) 1 (4.2) (OGT placed during EGD as well)
 Biliary decompression, n (%) 2 (8.3)
 Diarrhea, n (%) 1 (4.2)
 Obstruction, n (%) 1 (4.2)
Need for intervention, n (%) GI Bleed 2 (8.3)
Enteral feeding access 6 (25)
Biliary decompression 2 (8.3)
Endoscopic findings  
 Endoscopy n = 18, n (%) Enteral tube placement 6 (33.3)
Inflammation/ulcers 10 (55.6)
AVM 1 (5.6)
Varices 1 (5.6)
Normal 1 (5.6) (one for OGT placement)
 Colonoscopy n = 7, n (%) Diverticulosis 2 (8.6)
Hemorrhoids 3 (42.9)
Rectal ulcer 1 (14.3)
Blood without source 1 (14.3)
Normal 1 (14.3)
 ERCP n = 2, n (%) Choledocholithiasis 1 (50)
Biliary Sludge 1 (50)
 Related to COVID, n (%) Yes 2 (8.3)
No 22 (91.7)